Bacchetti, T <br/><br/>
Oxidative stress and psoriasis: the effect of antitumour necrosis factor-α inhibitor treatment.  [electronic resource] 

 -  The British journal of dermatology  May 2013 
 - 984-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1365-2133 
<br/><br/><label>Standard No.: </label>10.1111/bjd.12144  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aryldialkylphosphatase--metabolism<br/>Biomarkers--metabolism<br/>C-Reactive Protein--metabolism<br/>Etanercept<br/>Female<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Lipid Peroxidation--drug effects<br/>Lipids--blood<br/>Lipoprotein(a)--blood<br/>Lipoproteins, HDL--metabolism<br/>Male<br/>Middle Aged<br/>Oxidation-Reduction--drug effects<br/>Oxidative Stress--drug effects<br/>Psoriasis--blood<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Severity of Illness Index<br/>Time Factors<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors